Table 3. Prognostic factors for LRFS, DMFS, RFS and OS by multivariate Cox regression analysis in 255 ESCC patients.
| LRFS | DMFS | RFS | OS | |||||
|---|---|---|---|---|---|---|---|---|
| HR (95% CI) | P | HR (95% CI) | P | HR (95% CI) | P | HR (95% CI) | P | |
| Differentiation (poorly/well and moderately) | 0.987 (0.380–2.566) | 0.979 | 1.469 (0.895–2.413) | 0.128 | 1.381 (0.889–2.146) | 0.151 | 1.834 (1.095–3.073) | 0.021 |
| Tumor length (>5 cm/≤5 cm) | 0.925 (0.354–2.418) | 0.874 | 1.364 (0.849–2.201) | 0.204 | 1.301 (0.848–1.997) | 0.228 | 1.961 (1.211–3.174) | 0.006 |
| T stage (T3–4/T1–2) | 1.958 (0.819–4.679) | 0.131 | 1.039 (0.636–1.700) | 0.878 | 1.208 (0.785–1.860) | 0.390 | 1.797 (0.989–3.264) | 0.054 |
| N stage (N+/N−) | 1.995 (0.920–4.330) | 0.081 | 1.592 (1.010–2.509) | 0.045 | 1.740 (1.170–2.588) | 0.006 | 1.997 (1.203–3.304) | 0.007 |
| Plasma fibrinogen levels (High/normal) | 0.998 (0.479–2.077) | 0.995 | 2.541 (1.615–4.001) | <0.001 | 2.002 (1.360–2.946) | <0.001 | 1.728 (1.070–2.793) | 0.025 |
Bold values are statistically significant (P < 0.05).